Explainable Artificial Intelligence in the Field of Drug Research

Qingyao Ding,1 Rufan Yao,1 Yue Bai,1 Limu Da,1 Yujiang Wang,2 Rongwu Xiang,1,3,4 Xiwei Jiang,1 Fei Zhai1 1Faculty of Medical Devices, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, People’s Republic of China; 2Department of Internal Medicine, Zhengding County People’s Hospital, Shijiazhuang, Hebei Province, People’s Republic of China; 3Liaoning Medical Big Data and Artificial Intelligence Engineering Technology Research Center, Shenyang, Liaoning Province, People’s Republic of China; 4Institute of Regulatory Science for Medical Products, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, People’s Republic of ChinaCorrespondence: Xiwei Jiang, Faculty of Medical Devices, Shenyang Pharmaceutical University, Shenyang, 110016, People’s Republic of China, Email [email protected] Fei Zhai, Faculty of Medical Devices, Shenyang Pharmaceutical University, Shenyang, 110016, People’s Republic of China, Email [email protected]: In recent years, the widespread use of artificial intelligence (AI) and big data technologies in drug research has significantly accelerated the drug development process. However, their black-box nature makes it challenging to evaluate their effectiveness and safety. The interpretability of models has become a key issue in the application of AI in the drug development. In this paper, a bibliometric approach has been adopted to systematically analyze the application of Explainable Artificial Intelligence (XAI) techniques in drug research, with an in-depth discussion of the developmental trends, geographical distribution, journal preferences, major contributors, and research hotspots. In addition, the research results of XAI are summarized in the three directions of chemical, biological, and traditional Chinese medicine, and the future research directions and development trends are envisioned in order to promote the in-depth application of XAI technology in drug discovery and continuous innovation.Keywords: explainable artificial intelligence, XAI, drug research, bibliometric analysis, interpretability, shapley additive explanations, SHAP

Institutions

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-05-01
Primary Topic
Explainable Artificial Intelligence (XAI)
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Explainable Artificial Intelligence in the Field of Drug Research

SHILAP Revista de lepidopterología
Explainable Artificial Intelligence (XAI)
article

Explainable Artificial Intelligence in the Field of Drug Research

article en

Abstract

Qingyao Ding,1 Rufan Yao,1 Yue Bai,1 Limu Da,1 Yujiang Wang,2 Rongwu Xiang,1,3,4 Xiwei Jiang,1 Fei Zhai1 1Faculty of Medical Devices, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, People’s Republic of China; 2Department of Internal Medicine, Zhengding County People’s Hospital, Shijiazhuang, Hebei Province, People’s Republic of China; 3Liaoning Medical Big Data and Artificial Intelligence Engineering Technology Research Center, Shenyang, Liaoning Province, People’s Republic of China; 4Institute of Regulatory Science for Medical Products, Shenyang Pharmaceutical University, Shenyang, Liaoning Province, People’s Republic of ChinaCorrespondence: Xiwei Jiang, Faculty of Medical Devices, Shenyang Pharmaceutical University, Shenyang, 110016, People’s Republic of China, Email [email protected] Fei Zhai, Faculty of Medical Devices, Shenyang Pharmaceutical University, Shenyang, 110016, People’s Republic of China, Email [email protected]: In recent years, the widespread use of artificial intelligence (AI) and big data technologies in drug research has significantly accelerated the drug development process. However, their black-box nature makes it challenging to evaluate their effectiveness and safety. The interpretability of models has become a key issue in the application of AI in the drug development. In this paper, a bibliometric approach has been adopted to systematically analyze the application of Explainable Artificial Intelligence (XAI) techniques in drug research, with an in-depth discussion of the developmental trends, geographical distribution, journal preferences, major contributors, and research hotspots. In addition, the research results of XAI are summarized in the three directions of chemical, biological, and traditional Chinese medicine, and the future research directions and development trends are envisioned in order to promote the in-depth application of XAI technology in drug discovery and continuous innovation.Keywords: explainable artificial intelligence, XAI, drug research, bibliometric analysis, interpretability, shapley additive explanations, SHAP

SHILAP Revista de lepidopterología
Centre for Innovation in Regulatory Science (GB), The Medical Device (United Kingdom) (GB)
Industry, innovation and infrastructure
Openalex Percentile: Top 72%
Explainable Artificial Intelligence (XAI)
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Explainable Artificial Intelligence in the Field of Drug Research · SHILAP Revista de lepidopterología (2025) | TGRS Research Map | TGRS